Form D/A — J3 BIOSCIENCE, INC.
0001408012-26-000002 · filed Aug 27, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $2,791,250
- Reported amount sold
- $1,726,250
- Minimum investment
- $10,000
- Investors
- 23
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- J3 BIOSCIENCE, INC.
- CIK
- 1408012
- Entity
- Corporation
- Jurisdiction
- UTAH
- Year incorporated
- —
- Address
- 825 NORTH 300 WEST
SALT LAKE CITY, UT 84103 - Phone
- 801-931-4756
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
R. Tyler McCabe · Executive OfficerSalt Lake City, UT Find on LinkedIn ↗
-
Tim S. Glassett · Executive OfficerSalt Lake City, UT Find on LinkedIn ↗
-
Stath J. Karras · DirectorSalt Lake City, UT Find on LinkedIn ↗
-
Duck Joo Lee · DirectorSalt Lake City, UT Find on LinkedIn ↗
-
Troy E. Mason · DirectorSalt Lake City, UT Find on LinkedIn ↗
-
Ron E. Nielsen · DirectorSalt Lake City, UT Find on LinkedIn ↗
-
Sheryl A. Kingsberg · DirectorSalt Lake City, UT Find on LinkedIn ↗
-
Keith Marmer · DirectorSalt Lake City, UT Find on LinkedIn ↗
-
Stephanie Singer · DirectorSalt Lake City, UT Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗